The most significant modifiable risk factor for cardiovascular disease and the most prominent contributor to all-cause mortality is hypertension. Characterized by an office blood pressure of ≥140/90, hypertension is pervasive and impacts an estimated 25% of adults globally. Treatment for hypertension should include a number of lifestyle changes (ie. reduced ...
Indapamide is a diuretic indicated for use as monotherapy or in combination with other blood pressure-lowering agents to treat hypertension. It may also be used to treat fluid and salt retention associated with congestive heart failure.
Clinical Trial Site, Torpoint, United Kingdom
Clinical Trials Site, Beverly Hills, California, United States
Clinical Trial site, Winston-Salem, North Carolina, United States
Kunshan First Renmin Hospital, Kunshan, Jiangsu, China
Changzhi Heping Hospital, Changzhi, Shanxi, China
Dongtai Renmin Hospital, Dongtai, Jiangsu, China
Peking University Third Hospital, Beijing, Beijing, China
Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China
Cardiology, University and Emergency Hospital, Bucharest, Romania
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.